Back to Journals » Therapeutics and Clinical Risk Management » Volume 6

Critical appraisal of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia

Total article views   Abstract views HTML views PDF downloads Totals
12,091 Dovepress* 12,091 0+ 3,467 12,091
Totals 12,091 0 3,467 12,091
*Since 14 April 2010
+Since July 2016

View citations on Google Scholar